Scientific Workshop on Decentralized Clinical Trials in Hematology: Reshaping the Traditional Clinical Trial Paradigm With AI Strategies for 'Real World' Patient Representation
Program: Scientific Workshops
Session: Closing Remarks
Program: Scientific Workshops
Session: Closing Remarks
Friday, December 6, 2024, 4:55 PM-5:00 PM
Disclosures: Borate: Novartis: Consultancy; Abbvie: Consultancy; Incyte: Consultancy; Sumitomo: Consultancy; Beigene: Membership on an entity's Board of Directors or advisory committees; Vincerx Pharma: Membership on an entity's Board of Directors or advisory committees; BMS: Consultancy; Astellas: Consultancy; Rigel: Consultancy; Daiichi Sankyo: Consultancy; Takeda: Other: IDMC.
See more of: Closing Remarks
See more of: Scientific Workshop on Decentralized Clinical Trials in Hematology: Reshaping the Traditional Clinical Trial Paradigm With AI Strategies for 'Real World' Patient Representation
See more of: Scientific Workshops
See more of: Scientific Workshop on Decentralized Clinical Trials in Hematology: Reshaping the Traditional Clinical Trial Paradigm With AI Strategies for 'Real World' Patient Representation
See more of: Scientific Workshops
Previous Presentation
|
Next Presentation >>